amiodarone has been researched along with Obstructive Lung Diseases in 6 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this study was to evaluate the pulmonary effects of amiodarone in patients with heart failure, in those with chronic obstructive pulmonary disease (COPD) and in those undergoing a surgical procedure." | 9.08 | Pulmonary effect of amiodarone in patients with heart failure. The Congestive Heart Failure-Survival Trial of Antiarrhythmic Therapy (CHF-STAT) Investigators (Veterans Affairs Cooperative Study No. 320). ( Deedwania, PC; Fisher, SG; Fletcher, RD; Rohatgi, P; Singh, BN; Singh, SN, 1997) |
| "The purpose of this study was to evaluate the pulmonary effects of amiodarone in patients with heart failure, in those with chronic obstructive pulmonary disease (COPD) and in those undergoing a surgical procedure." | 5.08 | Pulmonary effect of amiodarone in patients with heart failure. The Congestive Heart Failure-Survival Trial of Antiarrhythmic Therapy (CHF-STAT) Investigators (Veterans Affairs Cooperative Study No. 320). ( Deedwania, PC; Fisher, SG; Fletcher, RD; Rohatgi, P; Singh, BN; Singh, SN, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Voshaar, T | 1 |
| Singh, SN | 1 |
| Fisher, SG | 1 |
| Deedwania, PC | 1 |
| Rohatgi, P | 1 |
| Singh, BN | 1 |
| Fletcher, RD | 1 |
| Delbanco, T | 1 |
| Hartman, EE | 1 |
| Kagawa, FT | 1 |
| Kirsch, CM | 1 |
| Jensen, WA | 1 |
| Wehner, JH | 1 |
| Pelucco, D | 1 |
| Bernabò Di Negro, G | 1 |
| Stanley, R | 1 |
| Comer, T | 1 |
| Taylor, JL | 1 |
| Saliba, D | 1 |
1 trial available for amiodarone and Obstructive Lung Diseases
| Article | Year |
|---|---|
Pulmonary effect of amiodarone in patients with heart failure. The Congestive Heart Failure-Survival Trial of Antiarrhythmic Therapy (CHF-STAT) Investigators (Veterans Affairs Cooperative Study No. 320).
Topics: Aged; Amiodarone; Carbon Monoxide; Heart Failure; Humans; Lung; Lung Diseases, Obstructive; Prospect | 1997 |
5 other studies available for amiodarone and Obstructive Lung Diseases
| Article | Year |
|---|---|
[Comments on the contribution by B.-D. Gonska (drug therapy). Amiodarone].
Topics: Amiodarone; Bronchial Hyperreactivity; Humans; Lung Diseases, Obstructive; Pulmonary Fibrosis; Risk | 1994 |
A 75-year-old man with congestive heart failure, 1 year later.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Delivery of Health Care; Empathy; Heart Failure; Humans; I | 2000 |
A 77-year-old man with bilateral pulmonary infiltrates and shortness of breath.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Dyspnea; Fatal Outcome; Heart Failure; Humans; Lung Diseas | 2000 |
[Amiodarone in the treatment of cardiac arrhythmias in the course of chronic obstructive bronchopneumopathy (COBP). Evaluation of the effects of the drug on respiratory function].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans; Lung Diseases, Obstructive; Male; Middl | 1978 |
Mexiletine-theophylline interaction.
Topics: Aged; Amiodarone; Cardiovascular Diseases; Dose-Response Relationship, Drug; Drug Interactions; Drug | 1989 |